Detection of pulmonary tuberculosis through mobile X-ray based active case-finding in Pakistan: a retrospective analysis from programmatic screening of1 214 289 individuals from 2017 to 2021

在巴基斯坦利用移动X射线主动发现肺结核病例:一项对2017年至2021年间1214289人进行的项目筛查的回顾性分析

阅读:3

Abstract

Recent evidence suggests that community-wide active case finding (ACF) can reduce tuberculosis (TB) incidence and prevalence. Mass-screening at the community level, supported by mobile digital chest X-ray units, is now being scaled up by programmes across high burden countries. However, there is limited evidence of case-detection yields from programmes conducting ACF at scale in low-resource settings. We retrospectively analysed aggregate data from mobile X-ray screening events (called 'camps') in Pakistan from Q3 2017 to Q2 2021. A total of 11 327 camps were conducted that screened 1 214 289 individuals and detected 7625 cases of All-Forms TB (AF-TB), among whom 3500 (45.9%) were bacteriologically confirmed (B+) and the remaining were treated empirically. The yield for B+ and AF-TB per 100 000 population screened nationally was 289 (95% CI: 279 to 298) and 631 (95% CI: 617 to 646), respectively. Yield of TB detected from screening was highly variable between regions of Pakistan, ranging from 70 to 678 per 100 000 B+ and 76 to 1136 per 100 000 for AF-TB. Our findings have two major lessons for TB programmes. First, there was significant geographical variation in yields of both B+ and AF-TB, supporting targeting of interventions in areas of high prevalence to maximise the intervention's effectiveness. Second, more than half of TB cases were treated empirically, and approaches to improve sample collection, linkage to diagnostics, non-sputum based tests and standardisation of treatment for bacteriologically unconfirmed TB need to be concurrently prioritised by programmes considering scale-up of mobile X-ray-based ACF.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。